16 studies found for:    Alzheimer's | Open Studies | United States, Utah
Show Display Options
RSS Create an RSS feed from your search for:
Alzheimer's | Open Studies | United States, Utah
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease
Condition: Alzheimer´s Disease
Interventions: Drug: LY3314814;   Drug: Placebo
2 Recruiting Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)
Condition: Alzheimer's Disease
Interventions: Drug: MK-7622;   Drug: Placebo;   Drug: AChEI
3 Recruiting Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Azeliragon;   Drug: Placebo
4 Recruiting Study Evaluating RVT-101 in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil Treatment: MINDSET Study
Condition: Alzheimer's Disease
Interventions: Drug: RVT-101;   Drug: Placebo
5 Recruiting Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
Condition: Alzheimer's Disease
Interventions: Drug: Piromelatine;   Drug: Placebo
6 Recruiting AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
Condition: Alzheimer's Disease
Interventions: Drug: AC-1204;   Drug: Placebo
7 Recruiting A Study of Gantenerumab in Patients With Mild Alzheimer Disease
Condition: Alzheimer Disease
Interventions: Drug: florbetapir;   Drug: gantenerumab;   Drug: placebo
8 Recruiting 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Aducanumab (BIIB037);   Drug: Placebo
9 Recruiting Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment
Interventions: Drug: ABT-957;   Other: Placebo
10 Recruiting CREAD Study" A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Crenezumab;   Drug: Placebo
11 Recruiting A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
Conditions: Healthy;   Alzheimer's Disease;   Mild Cognitive Impairment
Interventions: Drug: LY2599666;   Drug: Solanezumab;   Drug: Placebo SC;   Drug: Placebo IV
12 Recruiting A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD
Condition: Alzheimer Disease
Interventions: Biological: LY3002813;   Drug: Placebo
13 Recruiting SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease
Conditions: Mild-Moderate Alzheimer's Disease;   Healthy Elderly
Interventions: Biological: MEDI1814 for IV injection;   Biological: MEDI1814 for Subcutaneous Injection;   Biological: IV Placebo;   Biological: Placebo for Subcutaneous Injection
14 Recruiting Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Condition: Dementia
Intervention: Procedure: FDG-PET brain scan
15 Recruiting Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment
Condition: Breast Cancer
Intervention: Drug: FDG-PET, [18F]Flutemetamol
16 Recruiting Cognitive Training and Practice Effects in MCI
Condition: Mild Cognitive Impairment
Intervention: Behavioral: computerized cognitive exercises

Indicates status has not been verified in more than two years